Evidence map›Paper›PMID 24934177›Full record

ArticleMolecular psychiatry2014

Adenomatous polyposis coli protein deletion leads to cognitive and autism-like disabilities.

J L Mohn, J Alexander, A Pirone, C D Palka, S-Y Lee, L Mebane, P G Haydon, M H Jacob

Open access · bronzeAbstract read
In one paragraph

Article in Molecular psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. APC in the nervous system.Medical molecular morphology · 2026
    Review
  5. Review
  6. Review
  7. CTNNB1 syndrome mouse models.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

J L MohnDepartment of Neuroscience, Sackler Biomedical Graduate School, Tufts University, School of Medicine, Boston, MA, USA.
J AlexanderDepartment of Neuroscience, Sackler Biomedical Graduate School, Tufts University, School of Medicine, Boston, MA, USA.
A PironeDepartment of Neuroscience, Sackler Biomedical Graduate School, Tufts University, School of Medicine, Boston, MA, USA.
C D PalkaDepartment of Neuroscience, Sackler Biomedical Graduate School, Tufts University, School of Medicine, Boston, MA, USA.
S-Y LeeDepartment of Neuroscience, Sackler Biomedical Graduate School, Tufts University, School of Medicine, Boston, MA, USA.
L MebaneDepartment of Neuroscience, Sackler Biomedical Graduate School, Tufts University, School of Medicine, Boston, MA, USA.
P G HaydonDepartment of Neuroscience, Sackler Biomedical Graduate School, Tufts University, School of Medicine, Boston, MA, USA.
M H JacobDepartment of Neuroscience, Sackler Biomedical Graduate School, Tufts University, School of Medicine, Boston, MA, USA.
Tufts University · US

Funding

TUSM/T-NEMC CENTER FOR NEUROSCIENCE RESEARCH - Imaging CoreP30NS047243 · NINDS · TUFTS UNIVERSITY BOSTON · PI JACKSON, F ROB · 2003 to 2017
$10.0M
Training in Education and Critical Research SkillsK12GM074869 · NIGMS · TUFTS UNIVERSITY BOSTON · PI MOORE, CLAIRE L · 2006 to 2017
$8.5M
ULTRASTRUCTURAL ANALYSIS OF NEURONAL SYNAPTIC ANTIGENSR01NS021725 · NINDS · WORCESTER FOUNDATION FOR BIOMEDICAL RES · PI JACOB, MICHELE H. · 1985 to 2009
$2.8M
Molecular mechanisms of auditory nAChR synapse assemblyR01DC008802 · NIDCD · TUFTS UNIVERSITY BOSTON · PI JACOB, MICHELE H. · 2009 to 2013
$2.2M
Synapse Neurobiology Training ProgramT32NS061764 · NINDS · TUFTS UNIVERSITY BOSTON · PI BIEDERER, THOMAS · 2009 to 2019
$1.7M
NIDCD NIH HHS DC008802NIDCD NIH HHS R01 DC008802NIGMS NIH HHS K12 GM074869NINDS NIH HHS NS21725NINDS NIH HHS P30 NS047243NINDS NIH HHS R01 NS021725NINDS NIH HHS T32 NS061764NINDS NIH HHS T32-NS061764
6 · The paper itself

Abstract

Intellectual disabilities (IDs) and autism spectrum disorders link to human APC inactivating gene mutations. However, little is known about adenomatous polyposis coli's (APC's) role in the mammalian brain. This study is the first direct test of the impact of APC loss on central synapses, cognition and behavior. Using our newly generated APC conditional knock-out (cKO) mouse, we show that deletion of this single gene in forebrain neurons leads to a multisyndromic neurodevelopmental disorder. APC cKO mice, compared with wild-type littermates, exhibit learning and memory impairments, and autistic-like behaviors (increased repetitive behaviors, reduced social interest). To begin to elucidate neuronal changes caused by APC loss, we focused on the hippocampus, a key brain region for cognitive function. APC cKO mice display increased synaptic spine density, and altered synaptic function (increased frequency of miniature excitatory synaptic currents, modestly enhanced long-term potentiation). In addition, we found excessive β-catenin levels and associated changes in canonical Wnt target gene expression and N-cadherin synaptic adhesion complexes, including reduced levels of presenilin1. Our findings identify some novel functional and molecular changes not observed previously in other genetic mutant mouse models of co-morbid cognitive and autistic-like disabilities. This work thereby has important implications for potential therapeutic targets and the impact of their modulation. We provide new insights into molecular perturbations and cell types that are relevant to human ID and autism. In addition, our data elucidate a novel role for APC in the mammalian brain as a hub that links to and regulates synaptic adhesion and signal transduction pathways critical for normal cognition and behavior.

Indexed as

Adenomatous Polyposis Coli ProteinAnimalsAutistic Disorderbeta CateninCadherinsCognition DisordersDendritic SpinesDisease Models, AnimalExcitatory Postsynaptic PotentialsHippocampusLong-Term PotentiationMaleMaze LearningMice, KnockoutMiniature Postsynaptic PotentialsPyramidal CellsAdenomatous Polyposis Coli Proteinbeta CateninCadherinsCdh2 protein, mouseCTNNB1 protein, mouse

Identifiers

PMID24934177
PMCPMC4317257
OpenAlexW2069814630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.